Emerging evidence has indicated that DDX17 acts as a transcriptional coregulator [38] or a cofactor of microprocessors in cancer development, such as in non-small cell lung cancer, glioma cells, and hepatocellular carcinoma [39–41]. The gene discussed is DDX17; the disease is central nervous system cancer.